10-93687418-ACTT-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4_SupportingPP5_Moderate
The NM_145246.5(FRA10AC1):c.494_496delAAG(p.Glu165del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000264 in 1,515,708 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 7.3e-7 ( 0 hom. )
Consequence
FRA10AC1
NM_145246.5 disruptive_inframe_deletion
NM_145246.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.15
Genes affected
FRA10AC1 (HGNC:1162): (FRA10A associated CGG repeat 1) The protein encoded by this gene is a nuclear phosphoprotein of unknown function. This gene contains a tandem CGG repeat region within a CpG island that normally consists of 8-14 repeats but can expand to over 200 repeats. The repeat region is within the 5' UTR of some transcript variants, but is intronic to another variant. The expanded repeat allele is a fragile site and becomes hypermethylated, causing a reduction in gene expression. A disease phenotype has not been associated with expanded alleles. This gene is found within the rare FRA10A folate-sensitive fragile site. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_145246.5. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 10-93687418-ACTT-A is Pathogenic according to our data. Variant chr10-93687418-ACTT-A is described in ClinVar as [Pathogenic]. Clinvar id is 1722515.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRA10AC1 | NM_145246.5 | c.494_496delAAG | p.Glu165del | disruptive_inframe_deletion | 8/14 | ENST00000359204.5 | NP_660289.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRA10AC1 | ENST00000359204.5 | c.494_496delAAG | p.Glu165del | disruptive_inframe_deletion | 8/14 | 1 | NM_145246.5 | ENSP00000360488.3 | ||
FRA10AC1 | ENST00000482719.1 | n.521_523delAAG | non_coding_transcript_exon_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151980Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 7.33e-7 AC: 1AN: 1363728Hom.: 0 AF XY: 0.00000147 AC XY: 1AN XY: 678022
GnomAD4 exome
AF:
AC:
1
AN:
1363728
Hom.:
AF XY:
AC XY:
1
AN XY:
678022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74230
GnomAD4 genome
AF:
AC:
3
AN:
151980
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74230
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 04, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 26, 2023 | Published functional studies demonstrate a damaging effect [reduced protein expression] (von Elsner et al.., 2022); Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; This variant is associated with the following publications: (PMID: 35871492, 34694367) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -14
Find out detailed SpliceAI scores and Pangolin per-transcript scores at